(BTSG) BrightSpring Health - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10950A1060

Pharmacy, Home, Rehabilitation, Medication

BTSG EPS (Earnings per Share)

EPS (Earnings per Share) of BTSG over the last years for every Quarter: "2021-03": 0.21, "2021-06": 0.12, "2021-09": 0.19, "2022-09": -0.13, "2022-12": -0.33, "2023-03": -0.12, "2023-06": 0.02, "2023-09": -0.76, "2023-12": -0.04, "2024-03": -0.27, "2024-06": 0.12, "2024-09": -0.04, "2024-12": 0.08, "2025-03": 0.14,

BTSG Revenue

Revenue of BTSG over the last years for every Quarter: 2021-03: 1514.449, 2021-06: 1645.978, 2021-09: 1736.156, 2022-09: 1981.415, 2022-12: 1970.636, 2023-03: 2028.378, 2023-06: 2166.724, 2023-09: 2256.529, 2023-12: 2374.544, 2024-03: 2576.638, 2024-06: 2730.21, 2024-09: 2906.823, 2024-12: 3052.801, 2025-03: 2878.129,

Description: BTSG BrightSpring Health

BrightSpring Health Services, Inc. is a leading provider of home and community-based healthcare services in the United States, operating through its two main segments: Pharmacy Solutions and Provider Services. The companys comprehensive platform delivers a range of pharmacy and provider services, including clinical and supportive care, to Medicare, Medicaid, and insured populations. With a focus on patient-centric care, BrightSpring offers infused, injectable, and oral medication services, as well as highly skilled clinical home health care and rehabilitation services, including physical, speech, and occupational therapy, and applied behavioral analysis.

As a healthcare services company, BrightSpring operates in a growing market driven by an aging population and increasing demand for home-based care. The companys services are designed to support patients with complex needs, and its platform is built to provide high-quality, cost-effective care. With its headquarters in Louisville, Kentucky, BrightSpring has established itself as a significant player in the healthcare services industry, with a history dating back to 1974.

Analyzing the technical data, we can see that the stock is currently trading at $22.24, below its 20-day SMA of $23.58, indicating a potential short-term downtrend. However, the stock is above its 50-day SMA of $20.42 and 200-day SMA of $18.29, suggesting a longer-term uptrend. The ATR of 1.17 (5.25%) indicates moderate volatility. Considering the support and resistance levels, the stock has a strong support base between $17.0 and $18.7, and resistance around $23.0 and $23.9.

From a fundamental perspective, BrightSprings market capitalization is approximately $4.2 billion, with a P/E ratio of 89.30 and a forward P/E of 41.49. The companys return on equity is 3.50%, indicating room for improvement in terms of profitability. Given the current valuation and growth prospects, we can forecast that BrightSprings stock may experience a moderate increase in the short term, potentially reaching $25.00, driven by its growing revenue and expanding services. However, the high P/E ratio and volatility may pose risks, and investors should closely monitor the companys financial performance and industry trends.

Based on the analysis, our forecast is that BrightSpring Health Services, Inc. Common Stock (BTSG) will experience a gradual increase in value over the next quarter, driven by its strong market position, growing demand for home-based care, and expanding services. We predict that the stock will reach $24.50, representing a 10% increase from its current price. However, investors should be cautious of the potential risks and monitor the companys performance closely.

Additional Sources for BTSG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BTSG Stock Overview

Market Cap in USD 3,868m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Services
IPO / Inception 2024-01-26

BTSG Stock Ratings

Growth Rating 52.1
Fundamental 6.98
Dividend Rating 0.0
Rel. Strength 88.2
Analysts 4.67 of 5
Fair Price Momentum 21.88 USD
Fair Price DCF 13.02 USD

BTSG Dividends

Currently no dividends paid

BTSG Growth Ratios

Growth Correlation 3m 10.1%
Growth Correlation 12m 78.7%
Growth Correlation 5y 91.2%
CAGR 5y 49.73%
CAGR/Max DD 5y 1.40
Sharpe Ratio 12m 0.78
Alpha 57.45
Beta 0.914
Volatility 41.16%
Current Volume 1108k
Average Volume 20d 1710.1k
Stop Loss 19.2 (-3.8%)
What is the price of BTSG shares?
As of July 19, 2025, the stock is trading at USD 19.95 with a total of 1,107,985 shares traded.
Over the past week, the price has changed by -1.80%, over one month by -10.88%, over three months by +27.69% and over the past year by +71.50%.
Is BrightSpring Health a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, BrightSpring Health is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.98 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BTSG is around 21.88 USD . This means that BTSG is currently overvalued and has a potential downside of 9.67%.
Is BTSG a buy, sell or hold?
BrightSpring Health has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy BTSG.
  • Strong Buy: 9
  • Buy: 2
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for BTSG share price target?
According to our own proprietary Forecast Model, BTSG BrightSpring Health will be worth about 24.3 in July 2026. The stock is currently trading at 19.95. This means that the stock has a potential upside of +21.9%.
Issuer Target Up/Down from current
Wallstreet Target Price 28.1 40.9%
Analysts Target Price 27.3 36.8%
ValueRay Target Price 24.3 21.9%